Quadrature Capital’s Repligen RGEN Stock Holding History

Quadrature Capital’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-6,837	Closed	-$870K	–	1408
2025 Q1	$870K	Buy	+6,837	New	+$1.05M	0.02%	458

Other funds holding RGEN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Quadrature Capital's RGEN Position: Q2 2025 in Review

Quadrature Capital sold out of Repligen (RGEN) in Q2 2025, closing a stake of 6,837 shares — an estimated $870K sold.

Quadrature Capital first reported a position in RGEN in Q1 2025 and held it in 1 quarter. The position peaked at $870K in Q1 2025. 444 funds tracked by Wall St. Rank hold RGEN as of Q2 2025.

Quadrature Capital reported no remaining Repligen position as of Q2 2025 after selling out during the quarter.
Quadrature Capital sold 6,837 Repligen shares in Q2 2025, an estimated $870K.
Quadrature Capital first reported a position in Repligen in Q1 2025 and held it in 1 quarter.
Quadrature Capital's Repligen position peaked at $870K in Q1 2025.
444 funds tracked by Wall St. Rank held Repligen as of Q2 2025.

Based on Quadrature Capital's 13F filing for Q2 2025, filed 13 Aug 2025.